The report "Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030", is projected to grow from USD 1.61 billion in 2025 and to reach USD 2.41 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.
Browse 450 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on "Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-nucleic-acid-isolation-and-purification-market-157379732.html
Several factors are driving the development of the Europe nucleic acid isolation and purification market. A key driver is Europe’s extensive network of hospital laboratories, reference laboratories, and public health laboratories, which run high volumes of PCR/qPCR and NAAT testing as part of routine diagnostics and surveillance. This maintains strong demand for DNA/RNA extraction kits, including magnetic bead kits, spin columns, and cleanup buffers, on a day-to-day basis.
The kits segment accounted for the largest share of the Europe cell culture market in 2024.
On?????? the basis of products, the Europe nucleic acid isolation and purification market is divided into kits, reagents, and instruments. In the Europe nucleic acid isolation and purification market, kits dominated the product segment in 2024. This suggests that extraction is largely driven by consumables. Kits remain the most purchased product group because they enable repeatable performance across routine and high-volume lab settings. Magnetic bead kits and spin-column kits have been used continuously in Europe, as hospitals and diagnostic centers routinely process samples for PCR/qPCR and NAAT testing.
The hospitals & diagnostic centers segment dominated the market in 2024.
By?????? the end user, the market has been segmented into hospitals & diagnostic centers, academic & government research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users. In the Europe nucleic acid isolation and purification market, hospitals and diagnostic centers dominated the end-user segment in 2024. This is primarily due to their high daily workload of molecular diagnostics, particularly PCR/qPCR and NAAT testing. In these settings, DNA/RNA extraction is a mandatory first step before PCR and sequencing workflows. Hospitals also handle a diverse range of sample types, so they prefer standardized extraction to ensure consistent results.
Germany is expected to grow at the fastest rate in the Europe nucleic acid isolation and purification market during the forecast period.
By country, the Europe nucleic acid isolation and purification market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany is expected to report the highest growth rate during the forecast period in the Europe nucleic acid isolation and purification market. The market in Europe is distributed among the leading countries like Germany, the UK, France, Italy, and Spain. With the expansion of molecular workflows in both clinical and research settings, Germany is well-positioned to maintain its market dominance. One contributing factor is the abundance of hospital laboratories, reference labs, and centralized diagnostic centers that are actively performing a high volume of PCR/qPCR and NAAT testing. This activity ensures a steady demand for DNA and RNA extraction services.
Key companies active in the Europe nucleic acid isolation and purification market include Thermo Fisher Scientific (US), Danaher (US), QIAGEN (Germany), F. Hoffman-La Roche (Switzerland), and Agilent Technologies, Inc. (US), along with other regional and global companies.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/